Parallel Advisors, LLC Intercept Pharmaceuticals, Inc. Transaction History

Parallel Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 28, 2022	SELL	$13.37 - $17.79 $0 - $0	0 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$14.28 - $19.53 $0 - $0	0 New	0 $0
Q4 2020 Feb 02, 2021	SELL	$24.48 - $42.47 $146 - $254	-6 Closed	0 $0
Q3 2020 Oct 27, 2020	SELL	$39.09 - $53.44 $625 - $855	-16 Reduced 72.73%	6 $0
Q2 2019 Aug 05, 2019	SELL	$77.77 - $120.68 $7,777 - $12,068	-100 Reduced 81.97%	22 $2,000
Q1 2019 May 01, 2019	BUY	$91.83 - $120.68 $9,183 - $12,068	100 Added 454.55%	122 $14,000
Q2 2018 Jul 30, 2018	SELL	$60.0 - $85.67 $1,020 - $1,456	-17 Reduced 43.59%	22 $1,000
Q1 2018 May 08, 2018	BUY	$52.72 - $67.25 $2,056 - $2,622	39 New	39 $2,000
Q4 2017 Feb 13, 2018	SELL	$58.2 - $72.76 $814 - $1,018	-14 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$57.01 - $118.75 $798 - $1,662	14	14 $1,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.